Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
- PMID: 33643745
- PMCID: PMC7885304
- DOI: 10.7759/cureus.c41
Correction: Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
Abstract
[This corrects the article DOI: 10.7759/cureus.13002.].
Copyright © 2021, Siddiqui et al.
Conflict of interest statement
No competing interests declared.
Erratum for
-
Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines.Cureus. 2021 Jan 30;13(1):e13002. doi: 10.7759/cureus.13002. Cureus. 2021. PMID: 33542885 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources